Biological effect of orbital atherectomy and adjunctive paclitaxel-coated balloon therapy on vascular healing and drug retention: Early experimental insights into the familial hypercholesterolaemic swine model of femoral artery stenosis

EuroIntervention

Volumn 10, Issue 8, 2014, Pages 1002-1008

  Tellez, Armando ^a,d   Dattilo, Raymond ^b   Mustapha, Jihad A ^c   Gongora, Carlos A ^a   Hyon, Chelsea M ^a   Palmieri, Taylor ^a   Rousselle, Serge ^d   Kaluza, Greg L ^a   Granada, Juan F ^a,e  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b Vascular and Vein Clinic   (United States)

^c Metro Health Hospital   (United States)

^d Alizee Pathology   (United States)

^e Department of Medicine   (United States)

Author keywords

Animal models of disease; Familial hypercholesterolaemic swine; Orbital atherectomy

Indexed keywords

PACLITAXEL; ANTINEOPLASTIC AGENT;

ADD ON THERAPY; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTERY CALCIFICATION; ARTERY DIAMETER; ARTERY INJURY; ARTICLE; ATHERECTOMY; ATHERECTOMY DEVICE; ATHEROSCLEROTIC PLAQUE; BALLOON CATHETER; BALLOON CATHETERIZATION; CATHETER SHEATH; CHOLESTEROL DIET; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DEEP FEMORAL ARTERY; DRUG DISTRIBUTION; DRUG RETENTION; DRUG TISSUE LEVEL; ENDOVASCULAR SURGERY; EQUIPMENT DESIGN; FAMILIAL HYPERCHOLESTEROLEMIA; FEMORAL ARTERY STENOSIS; HISTOPATHOLOGY; IMAGING SYSTEM; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; INTRAVASCULAR ULTRASOUND CATHETER; ISOLATED ARTERY; MATERIAL COATING; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; ORBITAL ATHERECTOMY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHARMACOKINETIC ASSAY; PHARMACOKINETICS; PORCINE MODEL; PROCESS CONTROL; PROCESS DESIGN; PROCESS DEVELOPMENT; PROCESS MODEL; PROCESS TECHNOLOGY; RANDOMIZED CONTROLLED TRIAL; SUPERFICIAL FEMORAL ARTERY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TISSUE DISTRIBUTION; TISSUE HOMOGENATE; VASCULAR HEALING; VASCULAR PATENCY; WOUND HEALING; ANIMAL; COMPLICATION; CONSTRICTION, PATHOLOGIC; DISEASE MODEL; DRUG EFFECTS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FEMORAL ARTERY; MULTIMODALITY CANCER THERAPY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL ARTERIAL DISEASE; PIG; PROCEDURES;

ANGIOPLASTY, BALLOON; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATHERECTOMY; COMBINED MODALITY THERAPY; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; HYPERLIPOPROTEINEMIA TYPE II; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; SWINE; TOMOGRAPHY, OPTICAL COHERENCE; ULTRASONOGRAPHY, INTERVENTIONAL; WOUND HEALING;

EID: 84920110992     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY14M10_03     Document Type: Article

References (23)

1. Otsuka F, Nakano M, Sakakura K, Ladich E, Kolodgie FD, Virmani R. Unique demands of the femoral anatomy and pathology and the need for unique interventions. J Cardiovasc Surg (Torino). 2013;54:191-210.
2. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwálder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-99.
3. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J. Inhibition of restenosis in femoropopliteal arteries: paclitaxelcoated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358-65.
4. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL SMART Study Group. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004;25:342-8.
5. VilesGonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and lifethreatening consequences. Eur Heart J. 2004;25:1197-207.
6. Gornik HL, Beckman JA. Cardiology patient page. Peripheral arterial disease. Circulation. 2005;111:e169-72.
7. Almasood AS, Freixa X, Khan SQ, Seidelin PH, Džavík V. Stent fracture after everolimus-eluting stent implantation. Cardiol Res Pract. 2011;2011:320983.
8. Scheinert D, Scheinert S, Sax J, Piorkowski C, Bráunlich S, Ulrich M, Biamino G, Schmidt A. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-5.
9. Hassan AK, Bergheanu SC, Stijnen T, van der HoeveBL, Snoep JD, Plevier JW, Schalij MJ, Wouter Jukema J. Late stent malapposition risk is higher after drugeluting stent compared with baremetal stent implantation and associates with late stent thrombosis. Eur Heart J. 2010;31:1172-80.
10. Otsuka F, Nakano M, Ladich E, Kolodgie FD, Virmani R. Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement. Thrombosis. 2012;2012:6085-93. doi: 10.1155/2012/608593. [Epub 2012 Nov 21].
11. Cook S, Eshtehardi P, Kalesan B, Ráber L, Wenaweser P, Togni M, Moschovitis A, Vogel R, Seiler C, Eberli FR, Lüscher T, Meier B, Jüni P, Windecker S. Impact of incomplete stent apposition on longterm clinical outcome after drugeluting stent implantation. Eur Heart J. 2012;33:1334-43.
12. Szántó G, Thury A, Volford G, Hausinger P, Séllei Á, Ungi I. Visualisation of a coronary stent presenting late mechanical failure in an aberrant left circumflex artery with coronary computed tomography angiography and optical coherence tomography. EuroIntervention. 2013;8:1464-5.
13. Fanelli F, Cannavale A, Boatta E, Corona M, Lucatelli P, Wlderk A, Cirelli C, Salvatori FM. Lower limb multilevel treatment with drugeluting balloons: 6month results from the DEBELLUM randomized trial. J Endovasc Ther. 2012;19:571-80.
14. Moses JW, Carlier S, Moussa I. Lesion preparation prior to stenting. Rev Cardiovasc Med. 2004;5 Suppl 2:S16-21.
15. Milewski K, Tellez A, Aboodi MS, Conditt GB, Yi GH, Thim T, Stenoien M, McGregor JC, Gray WA, Virmani R, Granada JF, Kaluza GL. Paclitaxeliopromide coated balloon followed by 'bailout' bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation. EuroIntervention. 2011;7:362-8.
16. Manunga JM, Oderich GS. Orbital atherectomy as an adjunct to debulk difficult calcified lesions prior to mesenteric artery stenting. J Endovasc Ther. 2012;19:489-94.
17. HaslerRapacz J, Ellegren H, Fridolfsson AK, Kirkpatrick B, Kirk S, Andersson L, Rapacz J. Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet. 1998;76:379-86.
18. Prescott MF, McBride CH, HaslerRapacz J, Von Linden J, Rapacz J. Development of complex atherosclerotic lesions in pigs with inherited hyperLDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol. 1991;139:139-47.
19. Granada JF, Kaluza GL, Wilensky RL, Biedermann BC, Schwartz RS, Falk E. Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research. EuroIntervention. 2009;5:140-8.
20. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478-92.
21. Buszman PP, Milewski K, Zurakowski A, Pajak J, Jelonek M, Gąsior P, Peppas A, Tellez A, Granada JF, Buszman PE. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine. Catheter Cardiovasc Interv. 2013;83:325-33.
22. Milewski K, Afari ME, Tellez A, Aboodi MS, Kim JS, Cheng Y, Conditt GB, McGregor JC, Yi GH, Stenoien M, Langanki D, Krueger CG, Kaluza GL, Granada JF. Evaluation of efficacy and dose response of different paclitaxelcoated balloon formulations in a novel swine model of iliofemoral instent restenosis. JACC Cardiovasc Interv. 2012;5:1081-8.
23. Kelsch B, Scheller B, Biedermann M, Clever YP, Schaffner S, Mahnkopf D, Speck U, Cremers B. Dose response to Paclitaxelcoated balloon catheters in the porcine coronary overstretch and stent implantation model. Invest Radiol. 2011;46:255-63.